You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

CLINICAL TRIALS PROFILE FOR PRAMLINTIDE ACETATE


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for pramlintide acetate

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00042458 ↗ Evaluation of Dose-titration of Pramlintide During Initiation of Therapy in Patients Trying to Improve Glucose Control Completed AstraZeneca Phase 3 2002-04-01 This is a randomized, triple-blind, placebo-controlled, multicenter study to investigate the safety of pramlintide treatment using pramlintide dose-titration coupled with insulin adjustments in subjects with type 1 diabetes who are actively trying to improve their glycemic control.
NCT00042471 ↗ Evaluation of the Bioavailability of Pramlintide Completed AstraZeneca Phase 2 2002-06-01 This is a randomized, open-label, crossover study to examine the bioavailability of pramlintide in normal weight and overweight subjects with type 1 and type 2 diabetes mellitus using insulin.
NCT00042601 ↗ Evaluation of the Effect of Pramlintide on Satiety and Food Intake Completed AstraZeneca Phase 2 2002-07-01 This is a single center, randomized, blinded, placebo-controlled, two-period, cross-over study to evaluate the effect of pramlintide on satiety and food intake in normal-weight and obese non-diabetic subjects and in insulin-treated subjects with type 1 and type 2 diabetes.
NCT00044707 ↗ Evaluation of an Orally Administered Medication When Taken in Conjunction With Pramlintide Completed AstraZeneca Phase 2 2002-08-01 This is a randomized, single-blind, placebo-controlled, crossover study to examine the effect of pramlintide on the pharmacokinetics of an orally administered medication
NCT00107107 ↗ Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus Completed AstraZeneca Phase 3 2002-11-01 This is a multicenter, open-label extension study designed to examine the long-term safety of pramlintide treatment in subjects with type 1 diabetes who have successfully completed treatment in the parent study 137-150.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for pramlintide acetate

Condition Name

Condition Name for pramlintide acetate
Intervention Trials
Type 1 Diabetes Mellitus 6
Diabetes Mellitus, Type 1 5
Obesity 5
Type 2 Diabetes Mellitus 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for pramlintide acetate
Intervention Trials
Diabetes Mellitus, Type 1 13
Diabetes Mellitus 13
Diabetes Mellitus, Type 2 7
Body Weight 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for pramlintide acetate

Trials by Country

Trials by Country for pramlintide acetate
Location Trials
United States 208
Canada 2
Australia 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for pramlintide acetate
Location Trials
Florida 12
Texas 12
Oregon 11
California 11
New York 8
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for pramlintide acetate

Clinical Trial Phase

Clinical Trial Phase for pramlintide acetate
Clinical Trial Phase Trials
Phase 4 3
Phase 3 3
Phase 2 9
[disabled in preview] 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for pramlintide acetate
Clinical Trial Phase Trials
Completed 18
Not yet recruiting 1
Recruiting 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for pramlintide acetate

Sponsor Name

Sponsor Name for pramlintide acetate
Sponsor Trials
AstraZeneca 16
Juvenile Diabetes Research Foundation 3
Amylin Pharmaceuticals, LLC. 3
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for pramlintide acetate
Sponsor Trials
Industry 19
Other 11
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.